Abstract
CELLS of the mononuclear phagocyte system are the predominant cell producing HIV-1 in most tissues, including the central nervous system (CNS)1–4, spinal cord5, lung6 and skin7,8; infection is associated with dementia9,10, neuropathy11–13, pneumonitis9,14 and dermatitis15,16 respectively. Different HIV-1 isolates vary markedly in their ability to infect mononuclear phagocytes productively17,18. Here we describe molecular clones of a CNS-derived isolate, HIV-1JR–FL which can replicate efficiently in mononuclear phagocytes. Analysis by polymerase chain reaction of early events after infection indicates that the early phase of viral replication before reverse transcription determines tropism. Genetic mapping of the macrophage-tropic phenotype by construction of recombinant viruses indicates that mononuclear phagocyte infectivity can be determined by a 157-amino-acid region of the gp120 glycoprotein of HIV-1JR–FL. Significantly, this region is upstream from the previously defined CD4-binding domain19. We propose that at least one determinant for mononuclear phagocyte tropism involves target cell interactions with regions of gp120 distinct from the CD4-binding domain.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Koenig, S. et al. Science 233, 1089–1093 (1986).
Gabuzda, D. H. et al. Ann. Neurol. 20, 289–295 (1986).
Wiley, C. A., Schrier, R. D., Nelson, J. A., Lampert, P. W. & Oldstone, M. B. A. Proc. natn. Acad. Sci. U.S.A. 83, 7089–7093 (1986).
Gartner, S., Markovits, P., Markovitz, D. M., Betts, R. F. & Popovic, M. J. Am. med. Assn 256, 2365–2371 (1986).
Eilbott, D. J. et al. Proc. natn. Acad. Sci. U.S.A. 86, 3337–3341 (1989).
Chayt, K. J. et al. J. Am. med. Assn 256, 2356–2359 (1986).
Tschachler, E. et al. J. Invest. Dermatol. 88, 233–237 (1987).
Rappersberger, K. et al. Intervirology 29, 185–194 (1988).
Levy, R. M., Bredesen, D. E. & Rosenblum, M. L. J. Neurosurg. 62, 475–495 (1985).
Navia, B. A., Jordan, B. D. & Price, R. W. Ann. Neurol. 19, 517–524 (1986).
Petito, C. K. et al. New. Engl. J. Med. 312, 874–879 (1985).
Lipkin, W. I., Parry, G., Kiprov, D. & Abrams, D. Neurology 35, 1479–1483 (1985).
Cornblath, D. R., McArthur, J. C., Kennedy, P. G., Witte, A. S. & Griffin, J. W. Ann. Intern. Med. 21, 32–40 (1987).
Suffredini, A. F. et al. Ann. Intern. Med. 107, 7–13 (1987).
Johnson, T. M., Duvic, M., Rapini, R. P. & Rios, A. New Engl. J. Med 313, 1415 (1985).
Eisenstat, B. A. & Wormser, G. P. New Engl. J. Med. 311, 189 (1984).
Gartner, S. et al. Science 233, 215–219 (1986).
Koyanagi, Y. et al. Science 236, 819–822 (1987).
Lasky, L. A. et al. Cell 50, 975–985 (1987).
Levy, J. A. et al. Science 225, 840–842 (1984).
Adachi, A. et al. J. Virol. 59, 284–291 (1986).
Saiki, R. K. et al. Science 230, 1350–1354 (1985).
Saiki, R. K. et al. Science 239, 487–491 (1988).
Lee, H. et al. Science 244, 471–475 (1989).
Pang, S. et al. Nature 343, 85–90 (1990).
Arrigo, S. J., Weitsman, S., Rosenblatt, J. D. & Chen, I. S. Y. J. Virol. 63, 4875–4881 (1989).
Zack, J. A. et al. Cell 61, 213–222 (1990).
Cann, A. J. et al. J. Virol. 64, 4733–4742 (1990).
Cordonnier, A., Montagnier, L. & Emerman, M. Nature 340, 571–574 (1989).
Fisher, A. G. et al. Nature 334, 444–447 (1988).
Cheng-Mayer, C. et al. J. Virol. 64, 4390–4398 (1990).
Kowalski, M. et al. Science 237, 1351–1355 (1987).
Bolognesi, D. P. Molec. biol. Med. 7, 1–15 (1990).
Ho, D. D., Kaplan, J. C., Rackauskas, I. E. & Gurney, M. E. Science 239, 1021–1023 (1988).
Willey, R. L. et al. J. Virol. 62, 139–147 (1988).
Cordonnier, A., Montagnier, L. & Emerman, M. J. Virol. 63, 4464–4468 (1989).
Cann, A. J., Koyanagi, Y. & Chen, I. S. Y. Oncogene 3, 123–128 (1988).
Devereux, J., Haebesli, P. & Smithies, O. Nucleic Acids Res. 12, 387–395 (1986).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
O'Brien, W., Koyanagi, Y., Namazie, A. et al. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature 348, 69–73 (1990). https://doi.org/10.1038/348069a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/348069a0
This article is cited by
-
Generation of a Dual-Target, Safe, Inexpensive Microbicide that Protects Against HIV-1 and HSV-2 Disease
Scientific Reports (2018)
-
Prolonged persistence of a novel replication-defective HIV-1 variant in plasma of a patient on suppressive therapy
Virology Journal (2016)
-
The HAND Database: a gateway to understanding the role of HIV in HIV-associated neurocognitive disorders
BMC Medical Genomics (2015)
-
Cytosolic phospholipase A2 regulates alcohol-mediated astrocyte inflammatory responses in HIV-associated neurocognitive disorders
Cell Death Discovery (2015)
-
RNAi-Mediated CCR5 Knockdown Provides HIV-1 Resistance to Memory T Cells in Humanized BLT Mice
Molecular Therapy - Nucleic Acids (2015)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
